Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Testosterone Enanthate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 389Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Radius Pharma Expands Abaloparatide Licensing Agreement
    Radius Pharma Expands Abaloparatide Licensing Agreement

    09 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/951473/radius-pharmaceuticals-expands-abaloparatide-licensing-agreement-with-theramex-granting-additional-commercialization-rights-including-mexico-canada-south-africa-israel-and-russia

    ACCESSWIRE
    09 Dec 2024
    Share Share
    UK Watchdog Fines Viatris $1.9M Over Rule Breach In Theramex Probe
    UK Watchdog Fines Viatris $1.9M Over Rule Breach In Theramex Probe

    22 Nov 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/uk-watchdog-fines-viatris-19-mln-over-rule-breach-theramex-probe-2024-11-22/

    REUTERS
    22 Nov 2024
    Share Share
    Theramex Announces Agreement to Acquire the European Rights to Duphaston
    Theramex Announces Agreement to Acquire the European Rights to Duphaston

    10 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231002698068/en

    BUSINESSWIRE
    10 Oct 2023
    Share Share
    Theramex Enters Into Agreement With Radius Health to Commercialise ELADYNOS
    Theramex Enters Into Agreement With Radius Health to Commercialise ELADYNOS

    20 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230308005585/en

    BUSINESSWIRE
    20 Mar 2023
    Share Share
    Scottish Medicines Consortium accepts Theramex’ Bijuve HRT on NHS Scotland
    Scottish Medicines Consortium accepts Theramex’ Bijuve HRT on NHS Scotland

    13 Sep 2022

    // PHARMAPHORUM

    https://pharmaphorum.com/news/scottish-medicines-consortium-accepts-theramex-bijuve-hrt/

    PHARMAPHORUM
    13 Sep 2022
    Share Share
    Theramex Announces EC Marketing Authorization for Yselty in Uterine Fibroids
    Theramex Announces EC Marketing Authorization for Yselty in Uterine Fibroids

    17 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220617005176/en

    BUSINESSWIRE
    17 Jun 2022
    Share Share